Cogstate Limited (COGZF) Q2 2026 Earnings Call Transcript

SA Transcripts158.48K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Cogstate Limited (COGZF) Q2 2026 Earnings Call February 18, 2026 5:30 PM EST Company Participants Bradley O'Connor - CEO, MD & Executive DirectorDarren Watson - Chief Financial OfficerRachel Colite - Executive VP of Clinical Trials Conference Call Participants Rebecca Wilson Presentation Rebecca Wilson Good morning, everyone. Welcome to Cogstate's Full Year Results for Financial Year '25. I'm pleased to introduce on our call today, Brad O'Connor, Cogstate CEO and Managing Director; Darren Watson, our CFO; and Rachel Colite, our Executive VP of Clinical Trials. Before we get started, a reminder that this webinar is being recorded. [Operator Instructions] I'd like to now hand over to you, Brad. Bradley O'ConnorCEO, MD & Executive Director Thanks, Beck. Welcome, everybody, and thank you for joining us today. I'm really excited to bring you these results. We'll dig into the numbers, but I think what's really interesting is that, within Cogstate, we feel that the business is changing fairly substantially over the last 6 months. And through today's presentation, we're going to try and draw out those changes and the growth that we're seeing in the business as well as the financial results. So today's presentation, of course, includes forward-looking statements, and therefore, I note our disclaimer stating that this information in the presentation is general in nature. Obviously, encourage all investors to consider your own investment objectives and also to review in detail our 2025 annual report as well as the half year financial reports that we've released today. So with that, and before we get into the numbers, what I want to do is spend a couple of minutes just highlighting the trends that are driving our business. One of the key takeaways from this presentation is the expansion and diversification of both the portfolio of trials that we're working on as